Acura Pharma OTC Stock Target Price and Analyst Consensus

ACUR
 Stock
  

USD 0.01  0.00  0.00%   

The current analyst and expert consensus on Acura Pharma is Strong Buy, with 1 strong buy opinions. The current projected Acura Pharma target price consensus is 6.0 with 1 analyst opinions. The most common way Acura Pharma Cmn analysts use to provide recommendation to the public is financial statements analysis. Many experts also interview Acura Pharma executives and customers to further validate their buy or sell advice. Please note, the number of analysts providing the opinion is not sufficient to provide adequate consensus on Acura Pharma. We encourage you to use your own analysis of Acura Pharma Cmn to validate this buy or sell advice. Acura Pharma buy-or-sell recommendation module provides average expert sentiment on the projected Acura Pharma Cmn target price to derive its highest and lowest estimates based on its projected price volatility. Please continue to Macroaxis Advice on Acura Pharma to cross-verify analyst projections. Unlike analyst recommendations, Macroaxis provides advice only from the perspective of investor risk tolerance and investment horizon.
  

Acura Pharma Target Price Consensus

We track the performance of the top 100 financial experts across various large and mid-size financial boutiques. Acura target price is determined by taking all analyst projections and averaging them out. There is no one specific way to measure analysts performance other than comparing it to the past results via a very sophisticated attribution analysis. Acura target price projections below should be used in combination with other traditional price prediction techniques such as stock price forecasting, investor sentiment analysis, technical analysis, earnings estimate, and various momentum models.
Number of OpinionsOne
Lowered Outlook0
Raized Outlook0
Strong Buy
Most Acura analysts issue ratings four times a year, at intervals of three months. Ratings are usually accompanied by a target price to helps potential investors understand Acura stock's fair price compared to its market value. Analysts arrive at stock ratings after researching public financial statements of Acura Pharma Cmn, talking to its executives and customers, or listening to those companies' conference calls.
Macroaxis Advice   Exposure   Valuation

Acura Pharma Target Price Projection

Acura Pharma's current and average target prices are 0.01 and 6.00, respectively. The current price of Acura Pharma is the price at which Acura Pharma Cmn is currently trading. On the other hand, Acura Pharma's target price is what analysts think the otc stock is worth or could sell for in the future. The more significant the discrepancy between the two prices, the more it stimulates investors to act.

Current Price

Acura Pharma Market Quote on 1st of October 2022

Low Price0.01Odds
High Price0.01Odds

0.01

Target Price

Analyst Consensus On Acura Pharma Target Price

Low Estimate6.0Odds
High Estimate6.0Odds
Number of AnalystsOne
Standard Deviation0.0

6.0

Note that most analysts generally publish their price targets in research reports on specific companies, along with recommendations for the company's stock.Although price targets are often quoted in the financial news media, there could be a delay between the publication of the latest analyst outlook on Acura Pharma Cmn and the information provided on this page.

Acura Pharma Analyst Ratings

Acura Pharma's analyst otc stock recommendations are determined by taking an average estimate of all analysts we track and classifying them as Strong Buy, Buy, Hold, Strong Sell, or Sell. Ratings generally communicate what analysts sense about Acura Pharma otc stock, and they use a lot of effort and time to analyze it and arrive at a rating. That suggests that analyst recommendations are the outcome of an objective and thorough examination of Acura Pharma's financials, market performance, and future outlook by experienced professionals. Acura Pharma's historical ratings below, therefore, can serve as a valuable tool for investors.

Analyst Consensus Breakdown

Average Consensus Estimates

About Acura Pharma Target Price Projections

Acura Pharma's target price is an analyst's projection of its future price. Price targets can be assigned to all types of securities, from complex investment products to otc stocks such as Acura Pharma Cmn and even bonds. If the target price is unavailable, it is most likely because there were not enough analyst opinions to come up with a consensus estimate. When setting a price target estimate, an analyst is trying to determine what the OTC Stock is worth and where the price will be in a year from now. Generally, the target price of Acura depends on its intrinsic valuation, beta (i.e., risk over market), and overall volatility. Most analysts publish their price targets in research reports on specific companies, along with their buy, hold, or sell recommendations. Stock price targets are often quoted in the financial news media. Macroaxis uses multiple feeds to provide overall target price projection for Acura Pharma Cmn including its fundamental analysis.

Additional Acura Pharma Value Projection Modules

Most investment researchers agree that the mispricing and readjustment of any OTC Stock value happens often and is sometimes even predictable, but there is no strong theory explaining why it happens. The current price of Acura Pharma is a key component of Acura Pharma valuation and have some predictive power on the future returns of a Acura Pharma.
Sophisticated investors, who have witnessed many market ups and downs, frequently view the market will even out over time. This tendency of Acura Pharma's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy. Please use the tools below to analyze the current value of Acura Pharma in the context of predictive analytics.
Hype
Prediction
LowEstimated ValueHigh
0.000.0120.21
Details
Intrinsic
Valuation
LowReal ValueHigh
0.081.5121.71
Details
Naive
Forecast
LowNext ValueHigh
0.0011360.0620.26
Details
Bollinger
Band Projection (param)
LowerMiddle BandUpper
-0.020.0107810.042819
Details
Please note, it is not enough to conduct a financial or market analysis of a single entity such as Acura Pharma. Your research has to be compared to or analyzed against Acura Pharma's peers to derive any actionable benefits. When done correctly, Acura Pharma's competitive analysis will give you plenty of quantitative and qualitative data to validate your investment decisions or develop an entirely new strategy towards taking a position in Acura Pharma Cmn.

Trending Themes

If you are a self-driven investor, you will appreciate our idea-generating investing themes. Our themes help you align your investments inspirations with your core values and are essential building blocks of your portfolios. A typical investing theme is an unweighted collection of up to 20 funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of equities with common characteristics such as industry and growth potential, volatility, or market segment.
Investing
Invested over 90 shares
Macroaxis Index
Invested over 90 shares
Please continue to Macroaxis Advice on Acura Pharma to cross-verify analyst projections. Unlike analyst recommendations, Macroaxis provides advice only from the perspective of investor risk tolerance and investment horizon. You can also try Shere Portfolio module to track or share privately all of your investments from the convenience of any device.

Complementary Tools for analysis

When running Acura Pharma Cmn price analysis, check to measure Acura Pharma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Acura Pharma is operating at the current time. Most of Acura Pharma's value examination focuses on studying past and present price action to predict the probability of Acura Pharma's future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Acura Pharma's price. Additionally, you may evaluate how the addition of Acura Pharma to your portfolios can decrease your overall portfolio volatility.
Instant Ratings
Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance
Go
CEO Directory
Screen CEOs from public companies around the world
Go
Portfolio Volatility
Check portfolio volatility and analyze historical return density to properly model market risk
Go
Stock Tickers
Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites
Go
Bond Analysis
Evaluate and analyze corporate bonds as a potential investment for your portfolios.
Go
Competition Analyzer
Analyze and compare many basic indicators for a group of related or unrelated entities
Go
Stock Screener
Find equities using custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook.
Go
Watchlist Optimization
Optimize watchlists to build efficient portfolio or rebalance existing positions based on mean-variance optimization algorithm
Go
Analyst Recommendations
Analyst recommendations and target price estimates broken down by several categories
Go
Money Flow Index
Determine momentum by analyzing Money Flow Index and other technical indicators
Go
The data published in Acura Pharma's official financial statements usually reflect Acura Pharma's business processes, product offerings, services, and other fundamental events. But there are other numbers, ratios, or fundamental indicators derived from these statements that are easier to understand and visualize within the underlying realities that drive quantitative information of Acura Pharma Cmn. For example, before you start analyzing numbers published by Acura accountants, it's critical to develop an understanding of what Acura Pharma's liquidity, profitability, and earnings quality are in the context of the Healthcare space in which it operates.
Please note, the presentation of Acura Pharma's financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Acura Pharma's management is honest, while the outside auditors are strict and uncompromising. Whatever the case, the imprecision that can be found in Acura Pharma's accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of Acura Pharma Cmn. Please utilize our Beneish M Score to check the likelihood of Acura Pharma's management to manipulate its earnings.